Assessment of Prolonged Pain in Infants With Excessive Crying: the Role of Thermal Imaging
NEOTHERM
1 other identifier
observational
50
0 countries
N/A
Brief Summary
This study aims to propose a clinical assessment of chronic pain in infants using thermal imaging, by comparing the results of a validated behavioral scale (the EDIN) and a stress biomarker (salivary cortisol levels) with systematic thermal images of the body and face.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 9, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
ExpectedJuly 9, 2026
July 1, 2026
Same day
June 17, 2026
July 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Chronic pain in infants assessed using the EDIN scale: Neonatal Pain and Discomfort Scale
The EDIN is a validated behavioral scale for the heteroassessment of pain in newborns and infants up to 9 months of age. The EDIN scale includes 5 assessment criteria: facial expression, movements, sleep, interactive behavior, and comfort. Each item is scored on a 3-point scale based on symptom intensity; a score of 5 or higher indicates probable pain, and analgesia is recommended. It is easy to use, quick to administer (about 3 minutes), reliable (0.69), has good internal validity (0.92), and has the advantage of assessing prolonged pain.
2 month
Chronic Pain in Infants Assessed Using Capillary Cortisol Levels (hair samples weighing less than 2.5 mg)
Cortisol is a steroid hormone involved in the stress response. Capillary cortisol levels have been studied in newborns as a biomarker of chronic stress and are associated with chronic pain in adults. Capillary hair sampling is a noninvasive and rapid method; the samples are easy to store and remain stable over time. Protocols have been validated for the collection and analysis of capillary cortisol levels in preterm infants using hair samples weighing less than 2.5 mg. Translated with DeepL.com (free version)
2 month
Assessment of Chronic Pain in Infants Using Infrared Thermography
Full-body and facial thermographic images will be divided into regions of interest based on their vascular distribution. Asymmetries in body and facial temperatures will be systematically assessed. The child will be filmed in the supine position and then in the prone position, lying on their back, for 2 minutes on each side. Measurements will be taken using an OPTRIS 450 PI thermal camera. The images will then be analyzed by a specialized engineer who is blinded to the assignment group. Skin temperature regulation is central to the body's thermoregulation and is symmetrical and instantaneous under normal physiological conditions. Asymmetrical qualitative and quantitative changes in temperature indicate a metabolic, hemodynamic, or neurological alteration in thermoregulation in the affected region.
2 month
Secondary Outcomes (1)
Chronic pain in infants assessed using general motor skill analyses based on the Bayley Scale-4th edition
2 month
Study Arms (2)
Experimental group: excessive crying time
Infants between 3 and 9 weeks post-term (SPT) in corrected age who meet the ROME IV criteria for infant colic, with crying episodes lasting \> 3 hours per day for more than 3 days during the week prior to evaluation (modified Weissel criteria). No known neurological or gastrointestinal disorders. Consent from legal guardians.
Control group: physiological crying duration
Infants between 3 and 9 weeks post-term (SPT) in corrected age, whose daily crying time was less than 2 hours per day during the week preceding the evaluation. No known neurological or gastrointestinal disorders. Consent from legal guardians.
Eligibility Criteria
Experimental group: excessive crying duration Infants between 3 and 9 weeks post-term (SPT) in corrected age, meeting the ROME IV criteria for infant colic, with a crying duration of \> 3 hours per day for more than 3 days during the week preceding the evaluation (modified Weissel criteria). No known neurological or gastrointestinal pathology. Consent from legal guardians. Control group: physiological crying duration Infants between 3 and 9 weeks post-term (SPT) in corrected age, whose daily crying time was less than 2 hours per day during the week prior to the evaluation. No known neurological or gastrointestinal pathology. Consent from legal guardians.
You may qualify if:
- Infants between 3 and 9 weeks post-term (SPT) in corrected age.
- Meeting the ROME IV criteria for infant colic.
- With crying episodes lasting \> 3 hours per day for more than 3 days during the week preceding the evaluation (modified Weissel criteria).
- No known neurological or gastrointestinal pathology.
- Consent from legal guardians.
- Infants between 3 and 9 weeks post-term (SPT) in corrected age whose daily crying is less than 2 hours per day
- Consent from legal guardians.
You may not qualify if:
- Confirmed brain lesions (ultrasound/MRI).
- Major congenital or chromosomal abnormalities.
- Stunted growth and weight gain.
- Born before 37 weeks' gestational age.
- Legal guardians who do not speak French.
- Lack of consent from legal guardians.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2026
First Posted
July 9, 2026
Study Start
July 1, 2026
Primary Completion
July 1, 2026
Study Completion (Estimated)
July 1, 2028
Last Updated
July 9, 2026
Record last verified: 2026-07